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EDITORIAL
T
obacco smoking amplifies the negative impact
of Tuberculosis (TB) on population health. TB
patients who continue to smoke have much
worse treatment outcomes than those who quit. On
the other hand, TB patients are also more likely to quit
than general smokers if given appropriate advice and
support. In this editorial, we discuss how smoking
worsens TB outcomes, show how simple and cheap
interventions can help TB patients quit smoking
successfully and suggest how to sustain such
measures within a resource-constrained health
system.
Until recently, most medical texts on tobacco use did
not include TB as a tobacco-related disease.
However, by 2010 the global public health community
had recognised that TB outcomes are strongly
influenced by tobacco use. In 2010, both World Health
Organization and the International Union Against TB
and Lung Diseases warned against the dangerous
interaction between TB and smoking and referred
these as the two 'colliding epidemics'. A growing
body of evidence demonstrates that people who
smoke have approximately twice the risk of acquiring
TB infection and developing active TB disease.
Smoking in TB patients results in poor treatment
outcomes, including TB-related deaths, and
increased severity of disease with more cavitory
lesions and greater likelihood of hospitalization.
Smoking is associated with poorer adherence to anti-
TB medicines, higher risk of relapse after the initial
treatment and the development of multi-drug resis-
tance TB. Smokers, due to their longer infectivity
period and a higher treatment default rate, are also
more likely to transmit TB to others than non-smokers.
This interaction between TB and tobacco epidemics is
responsible for over 15-20% of TB-related deaths,
which could amount to an excess of 40 million TB
deaths by 2050. Given that Pakistan is one of the
high-burden countries for TB with a high smoking
prevalence, the interaction between TB and tobacco
poses a national public health threat.
While smoking in TB patients causes devastating
consequences, offering appropriate tobacco cessa-
tion support during TB treatment could lead to
substantial benefits. Most immunological abnormali-
ties in TB patients induced by smoking tobacco could
be reversed within six weeks of quitting. Smoking
cessation could reduce the risk of death due to TB by
more than half (65%). Moreover, TB patients are more
likely to follow cessation advice and succeed in
quitting than general smokers. TB patients have an
imminent fear of death and the possibility of infecting
others. This provides a 'teachable moment' that could
be capitalized by the TB health workers by reinforcing
benefits of quitting smoking in TB. There is now
growing evidence to suggest that brief behavioural
interventions could result in substantial number of TB
patients quitting smoking permanently. A seminal
study (The ASSIST trial), conducted in Pakistan
between 2010-2012, found that behavioural support
was seven to eight times more successful than usual
care in achieving smoking cessation among presump-
tive TB patients. The study also found that TB diagno-
sis was the strongest predictor to quit smoking
permanently. Other studies have also found that TB
patients are highly likely to respond to behavioural
support and quit resulting in improved TB treatment
adherence and reduced TB treatment failure rates.
Given the benefits of offering cessation support to TB
patients, it makes complete sense to provide such
interventions as part of routine care within respective
TB programmes. In the ASSIST trial, we found that
offering behavioural support intervention was highly
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cost-effective (10 USD per quit) when delivered by
TB DOTS (Directly Observed Treatment Short-course)
facilitators - paramedics responsible for registering
new TB patients, educating them about TB and
ensuring treatment compliance. Another study in
Brazil found that TB DOTS paramedics could be
trained to deliver smoking cessation support,
effectively in a TB clinic. WHO also emphasised that
tobacco control activities needs implementing as an
integral part of TB case management at primary health
care facilities. It is recommended that health facilities
record and report smoking status for all patients and
healthcare workers are trained to give brief advice on
smoking cessation. However, smoking cessation has
so far not been integrated within the recording and
reporting and supervision and monitoring mecha-
nisms within TB programmes. As a consequence,
most TB patients are neither asked about their
smoking status nor given any advice in this regard.
In conclusion, there is now a substantial body of
evidence that links smoking with adverse health
consequences for TB patients and shows that
continued smoking is counterproductive to their
treatment efforts. Furthermore, good evidence on the
effectiveness of behavioural support for tobacco
cessation in TB patients has emerged in recent years.
However, smoking cessation is generally not offered
as part of routine TB care even in countries with high
TB incidence and high tobacco use. Integrating
tobacco cessation within TB programmes offers a
viable solution to reduce TB and tobacco-related
disease burden. To this effect, we make following
recommendations: (a) Develop smoking cessation
guidelines for TB programmes; (b) Train TB DOTS
workers/providers to record smoking status and to
offer brief cessation advice; (c) Mandate recording
and reporting smoking status for all TB patients; and
(d) Support healthcare workers in quitting smoking
themselves.
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